Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

VIGL

Vigil Neuroscience (VIGL)

Vigil Neuroscience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VIGL
DateTimeSourceHeadlineSymbolCompany
12/19/20246:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIGLVigil Neuroscience Inc
11/14/202410:00AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VIGLVigil Neuroscience Inc
11/12/20247:00AMGlobeNewswire Inc.Vigil Neuroscience to Present at Upcoming Investor ConferencesNASDAQ:VIGLVigil Neuroscience Inc
11/07/20247:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VIGLVigil Neuroscience Inc
11/07/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
11/07/20247:00AMGlobeNewswire Inc.Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:VIGLVigil Neuroscience Inc
11/05/20247:00AMGlobeNewswire Inc.Vigil Neuroscience to Present at Guggenheim Healthcare Innovation ConferenceNASDAQ:VIGLVigil Neuroscience Inc
10/09/20246:22PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:VIGLVigil Neuroscience Inc
09/19/20245:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VIGLVigil Neuroscience Inc
09/17/20247:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
09/17/20247:00AMGlobeNewswire Inc.Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927NASDAQ:VIGLVigil Neuroscience Inc
09/16/20244:05PMGlobeNewswire Inc.Vigil Neuroscience to Present at Cantor Global Healthcare ConferenceNASDAQ:VIGLVigil Neuroscience Inc
08/29/20247:00AMGlobeNewswire Inc.Vigil Neuroscience to Present at Upcoming September Investor ConferencesNASDAQ:VIGLVigil Neuroscience Inc
08/13/20247:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VIGLVigil Neuroscience Inc
08/13/20247:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
08/13/20247:00AMGlobeNewswire Inc.Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:VIGLVigil Neuroscience Inc
08/12/20245:02PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:VIGLVigil Neuroscience Inc
08/01/20244:05PMGlobeNewswire Inc.Vigil Neuroscience Highlights Publication on ALSP Genetic Mutation Prevalence in Neurology GeneticsNASDAQ:VIGLVigil Neuroscience Inc
07/30/20244:05PMGlobeNewswire Inc.Vigil Presents Data on its Small Molecule TREM2 Agonist Program at 2024 Alzheimer's Association International Conference (AAIC)  NASDAQ:VIGLVigil Neuroscience Inc
07/24/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
07/24/20247:00AMGlobeNewswire Inc.Vigil Neuroscience Announces Interim Data from its Ongoing Phase 1 Clinical Trial Evaluating VG-3927 in Healthy Volunteers Supporting Continued Development in Alzheimer’s DiseaseNASDAQ:VIGLVigil Neuroscience Inc
07/18/20244:05PMGlobeNewswire Inc.Vigil Announces Upcoming Presentations on its Small Molecule TREM2 Agonist VG-3927 at the 2024 Alzheimer's Association International ConferenceNASDAQ:VIGLVigil Neuroscience Inc
07/18/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
07/18/20247:00AMGlobeNewswire Inc.Vigil Neuroscience Provides Update on Clinical Development Strategy to Pursue Potential Accelerated Approval Pathway for Iluzanebart in ALSPNASDAQ:VIGLVigil Neuroscience Inc
06/27/20242:00AMGlobeNewswire Inc.Vigil Neuroscience Announces $40 Million Strategic Investment from SanofiNASDAQ:VIGLVigil Neuroscience Inc
06/07/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIGLVigil Neuroscience Inc
06/07/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIGLVigil Neuroscience Inc
06/06/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
05/30/20247:05AMGlobeNewswire Inc.Vigil Neuroscience to Present in Upcoming June Investor ConferencesNASDAQ:VIGLVigil Neuroscience Inc
05/08/20247:40AMGlobeNewswire Inc.Vigil Neuroscience to Present at The Citizens JMP Life Sciences ConferenceNASDAQ:VIGLVigil Neuroscience Inc
 Showing the most relevant articles for your search:NASDAQ:VIGL